Jaspreet advises market-leading tech and healthcare companies on issues at the cutting-edge of digital health.
She focuses on the development and regulation of healthcare technology. This includes assessing how digital health solutions can comply with the legal framework for data privacy, medical research and medical devices / pharmaceuticals.
Jaspreet advises clients on complex issues at the intersection of healthcare, data and technology. Her practice has a particular focus on accessing and using patient data, innovative collaborations with hospitals, and the use and regulation of AI in the healthcare space.
Many healthcare lawyers in the City profess to understand the interplay between data privacy and healthcare regulatory regimes, but Jaspreet has a mastery of it that is unique in the market. She has spoken at various cutting edge symposia across Europe on these topics, including most recently various events by the Association of the British Pharmaceutical Industry on digital health and the regulation of innovation, and a Drug Industry Association 2019 event in Amsterdam on data privacy and medical research. Jaspreet is fast becoming established as a key voice and trusted adviser in this important space.
Representative Legal Matters
Advising a tech company on use of medical datasets from academic and medical institutions across the globe, for the purposes of validating an AI product in a wider patient population.
Advising a consultancy firm on the application of medical device legislation to an AI algorithm capable of providing diagnostic support to clinicians assessing mammograms.
Supporting a medtech company in collaborating with an NHS trust to set up a new lab providing diagnostic services to other UK hospitals.
Supporting a medtech company in contracting with NHS trusts across the UK for the supply of robotic surgical equipment, software and related consumables.
Advising providers of pharmaceutical homecare services on the use of patient data for a range of purposes in light of data privacy laws and NHS information governance requirements.
Advising various pharmaceutical companies, medtech companies and tech companies on the use of patient data and the data of healthcare professionals for a range of purposes, including for the development of healthcare technologies, for direct marketing and for the provision of NHS-commissioned services.
Supporting a pharmaceutical company on the launch of an app for patients and related publicity.
Advising a pharmaceutical company on facilitating market access to unlicensed medicines across the Middle East and outside the EU through early access to medicine schemes.
- England & Wales~United Kingdom (2015)
- College of Law (Legal Practice Course Distinction) (2012)
- King's College London, UK (LLB (Hons) Law with European Legal Studies) (First Class) (2011)
- Legal basis for processing personal data in clinical trials - what's the right approach?, PLC ,May 2019
- Author, "Practice Note on the Regulation of E-Cigarettes," LexisPSL, February 2019